Eventide Asset Management’s Silence Therapeutics SLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-640,000
Closed -$4.4M 255
2024
Q4
$4.4M Hold
640,000
0.08% 157
2024
Q3
$11.6M Buy
+640,000
New +$11.6M 0.2% 115